Healthcare Equipment and Supplies
Company Overview of Enopace Biomedical Ltd.
Enopace Biomedical Ltd. develops neuromodulation system to treat patients with congestive heart failure. It provides implantable neurostimulation, a device that is used to cure cardiovascular disease. The company was founded in 2008 and is based in Caesarea, Israel.
15 Alon Hatavor Street
Founded in 2008
972 4 637 8827
972 4 637 8533
Key Executives for Enopace Biomedical Ltd.
Similar Private Companies By Industry
|2P2D Solutions Ltd.||Middle East/Africa|
|3NT Medical Ltd.||Middle East/Africa|
|4C Diagnostics Ltd.||Middle East/Africa|
|A.B. Dental Devices, Limited||Middle East/Africa|
|Accurate Medical Therapeutics Ltd.||Middle East/Africa|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|The Advertising Council, Inc.||United States|
|Tax Management Inc||United States|
|John F. Kennedy Center For The Performing Arts||United States|
|NYC2012, Inc.||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Enopace Biomedical Ltd., please visit www.enopace.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.